Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 528
  • Home
  • Print this page
  • Email this page
REVIEW ARTICLE
Year : 2022  |  Volume : 27  |  Issue : 1  |  Page : 1-7

Blinding and its quality in clinical trials conducted on patients with breast cancer: A systematic review


1 Medical-Surgical Nursing Department, School of Nursing and Midwifery, Tehran University of Medical Science, Tehran, Iran
2 >Medical-Surgical Nursing Department, School of Nursing and Midwifery, Tehran University of Medical Science, Tehran, Iran
3 Clinical Care Research Center, Research Institute for Health Development, Kurdistan university of Medical Science, Sanandaj, Iran
4 Department of Adult Health, Faculty of Nursing and Midwifery, Isfahan University of Medical Sciences, Iran
5 Department of Medical-Surgical Nursing, School of Nursing and Midwifery, Tehran, Iran
6 Nursing and Midwifery Care Research center, School of Nursing and Midwifery, Tehran University of Medical Sciences, Tehran, Iran
7 School of Nursing and Midwifery, Isfahan University of Medical Sciences, Isfahan, Iran

Correspondence Address:
Dr. Nahid Dehghan Nayeri
Nursing and Midwifery Care Research Center, School of Nursing and Midwifery, Tehran University of Medical Sciences, Tehran
Iran
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijnmr.IJNMR_49_20

Rights and Permissions

Background: Blinding is one of the critical criteria of clinical trials that prevents probable bias. Judgment regarding results of an intervention significantly depends on the quality of such studies, one of which is blinding. This study aimed to investigate blinding and its quality in clinical trials in patients with breast cancer. Materials and Methods: A systematic review was conducted on the online databases of PubMed, ScienceDirect and ProQuest using keywords, MeSH terms and grey literature. Articles were screened by predefined inclusion and exclusion criteria. They were evaluated based on the checklists introduced by Cochrane database. Results: From 22519 articles obtained at the initial stage, 20 articles remained after screening for the inclusion and exclusion criteria. Fifteen articles had used single, five: double and none had used triple or quadruple blinding. Seventeen studies had described the details of blinding. Of the 15 single blind articles, the blinded subjects were patients in five, patients and research assistants in three, research assistants in five studies, and two had not given any details. Conclusions: The majority of researchers had used the single blind method, though using double, triple or quadruple blinding increases the trustworthiness of results and increases the quality of clinical trials. The details of blinding should be explained to other researchers and for a better understanding of the method if it is to be repeated. Thereafter, nurses can apply new interventions and earn their patients' trust and help those with breast cancer by relieving them of their disease symptoms and its treatment complications.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1005    
    Printed20    
    Emailed0    
    PDF Downloaded182    
    Comments [Add]    

Recommend this journal